Sutuchcha Ajchariyawongkul Joins PReMA Board of Directors

Bristol Myers Squibb (BMS) Thailand is proud to announce that Pomme Sutuchcha Ajchariyawongkul, Country Manager, Thailand & Vietnam, has been elected to the Board of Directors of the Pharmaceutical Research and Manufacturers Association (PReMA) for the 2026–2027 term.

The appointment was confirmed at PReMA’s Annual General Meeting (AGM), held on 11 December, where member companies came together to elect the new Board and reflect on the year’s achievements.

Sutuchcha was among seven industry leaders elected to the Board, representing leading multinational pharmaceutical companies committed to advancing Thailand’s healthcare ecosystem and strengthening collaboration across the sector.

With more than 24 years of experience in the Thai pharmaceutical industry, Sutuchcha brings deep insight into the local healthcare landscape, alongside extensive leadership experience across commercial strategy, market access, operations and cross‑functional collaboration.

In her current role at Bristol Myers Squibb, she provides overall business and commercial leadership, overseeing strategy execution, market development, and organizational performance, while driving access to innovative medicines and building strategic partnerships to support sustainable healthcare outcomes in Thailand and the region.

Commenting on her election, Sutuchcha Ajchariyawongkul said:

At the AGM, PReMA also confirmed the continuation of several existing Board members for a further one‑year term, reinforcing stability and continuity in advancing the association’s strategic priorities.

Bristol Myers Squibb congratulates Pomme Sutuchcha on her election and looks forward to her contribution to PReMA’s mission of promoting innovation, improving patient outcomes and strengthening Thailand’s healthcare ecosystem.